June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Yap1 is required for maintaining adult RPE differentiation
Author Affiliations & Notes
  • Qiutang Li
    DOVS, University of Louisville , Louisville, Kentucky, United States
  • Patrick A Scott
    DOVS, University of Louisville , Louisville, Kentucky, United States
  • Eric Vukmanic
    DOVS, University of Louisville , Louisville, Kentucky, United States
  • Lei Xue
    School of Life Science and Technology , Tongji University, Shanghai, China
  • Douglas C Dean
    DOVS, University of Louisville , Louisville, Kentucky, United States
  • Henry J Kaplan
    DOVS, University of Louisville , Louisville, Kentucky, United States
  • Qingxian Lu
    DOVS, University of Louisville , Louisville, Kentucky, United States
  • Footnotes
    Commercial Relationships   Qiutang Li, None; Patrick Scott, None; Eric Vukmanic, None; Lei Xue, None; Douglas Dean, None; Henry Kaplan, None; Qingxian Lu, None
  • Footnotes
    Support  Supported in part by NH Grant EY027033 and an unrestricted grant from Research to Prevent Blindness Inc., New York, NY
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1043. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qiutang Li, Patrick A Scott, Eric Vukmanic, Lei Xue, Douglas C Dean, Henry J Kaplan, Qingxian Lu; Yap1 is required for maintaining adult RPE differentiation. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1043.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Transcriptional coactivator YAP1 is a major downstream effector of the evolutionarily conserved Hippo pathway that controls organ size by regulating stem cell/progenitor cell proliferation and apoptosis during early development. The importance of YAP1 to the eye was further illustrated by the discovery of the heterozygous mutations in YAP1 causing coloboma in man, and the mutation in YAP1 binding domain of TEAD1 responsible for Sveinsson's chorioretinal atrophy (SCRA). However, YAP1 function in maintenance of RPE phenotype has not been investigated. This study aims to dissect YAP1 function and its regulatory mechanism in RPE cells.

Methods : To directly test the role of YAP1 in the differentiated RPE, we crossed Yap1 floxed mice with these carrying a Cre recombinase driven by the Best1 promoter, which is activated in the differentiated RPE cells. We investigated the phenotypes progressively developed in the Yap1-/- RPE in a timecourse up to 12 months old, using (1) EM for ultrastructure; (2) Immunohistochemistry for markers delineating RPE differentiation status, cell polarity, cell contact, microvilli organization, and cytoskeletal arrangement; (3) RPE barrier assay with fluorescent angiography; and (4) ERG for visual function. Additionally, we also performed the qPCR and Western blot to characterize molecular changes including these in the Wnt/β-catenin signaling pathway.

Results : Yap1 mutation in differentiated RPE caused diminished tight junctions, cell depolarization and RPE65 loss, retraction of microvilli and loss of pigment. These phenotypes are classic features of epithelial-mesenchymal transition (EMT), which are also evident in RPE during proliferative vitreoretinopathy (PVR). When getting older, the RPE-conditional Yap1 knockout mice exhibited impaired barrier function of RPE cells, disrupted and diminished choriocapillaris, outer segment loss in the adjacent photoreceptors, and abnormal electrophysiology. The photoreceptors in the conditional knockout mice eventually died between 6-12 months of age. Interestingly, β-catenin expression and its transcriptional activity was significantly increased in the mutant RPE.

Conclusions : YAP1 plays a critical role in maintenance of the RPE differentiating phenotype by downregulation of nuclear β-catenin; and thus, maintaining a constant inhibition of Wnt/β-catenin signaling prevents dedifferentiating EMT in normal adult RPE.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.